Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orthopediatrics Corp (NQ: KIDS )

30.48 -0.96 (-3.05%)
Streaming Delayed Price Updated: 3:22 PM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthopediatrics Corp

< Previous 1 2 3 4 Next >
OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
Increases IPOS Corporate Partnership as Emerald-Level Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in Upcoming November Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results
Record Setting Quarterly Revenue of $40.0 million 
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
4 Analysts Have This to Say About OrthoPediatrics
Via Benzinga
OrthoPediatrics's Earnings: A Preview
Via Benzinga
Analyst Ratings for OrthoPediatrics
Via Benzinga
OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics's Earnings Outlook
Via Benzinga
OrthoPediatrics Joins Alliance for Pediatric Device Innovation
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches DF2 Brace®
From OrthoPediatrics Corp.
Via GlobeNewswire
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company Showcase
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results
Record Setting Quarterly Revenue of $39.6 million 
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
First Quarter 2023 Revenue Increased 35% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting
Establishes Longer-term Commitment as an Emerald Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
OrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw System
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate at the 22nd Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.